AstraZeneca PLC (LON:AZN)
London · Delayed Price · Currency is GBP · Price in GBX 12,738
+14 (0.11%)
Oct 14, 2025, 7:12 PM BST
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 197.53 billion as of October 14, 2025. Its market cap has increased by 6.50% in one year.
Market Cap
197.53B
Enterprise Value
216.45B
Revenue
41.24B
Ranking
n/a
PE Ratio
32.88
Stock Price
12,738.00
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 197.53B, an increase of 4,240.90%. That is a compound annual growth rate of 12.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 197.53B | 21.72% |
| Dec 31, 2024 | 162.29B | -1.22% |
| Dec 29, 2023 | 164.29B | -5.48% |
| Dec 30, 2022 | 173.83B | 29.30% |
| Dec 31, 2021 | 134.44B | 39.83% |
| Dec 31, 2020 | 96.14B | -3.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GSK plc | 65.48B |
| Haleon | 30.16B |
| Smith & Nephew | 11.22B |
| ConvaTec Group | 4.82B |
| Hikma Pharmaceuticals | 3.99B |
| HUTCHMED (China) | 1.99B |
| Genus | 1.70B |
| Oxford Nanopore Technologies | 1.41B |